{'fraction_non_alphanumeric': 0.03356367226061204, 'fraction_numerical': 0.00839091806515301, 'mean_word_length': 5.602605863192182, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Perfluorododecanoic acid-induced steroidogenic inhibition is associated with steroidogenic acute regulatory protein and reactive oxygen species in cAMP-stimulated Leydig cells.

Perfluorododecanoic acid (PFDoA) can be detected in environmental matrices and human serum and has been shown to inhibit testicular steroidogenesis in rats. However, the mechanisms that are responsible for the toxic effects of PFDoA remain unknown. The aims of this study were to investigate the mechanism of steroidogenesis inhibition by PFDoA and to identify the molecular target of PFDoA in Leydig cells. The effects of PFDoA on steroid synthesis in Leydig cells were assessed by radioimmunoassay. The expression of key genes and proteins in steroid biosynthesis was determined by real-time PCR and Western blot analysis. Reactive oxygen species (ROS) and hydrogen peroxide (H(2)O(2)) levels were determined using bioluminescence assays. PFDoA inhibited adenosine 3',5'-cyclophosphate (cAMP)-stimulated steroidogenesis in mouse Leydig tumor cells (mLTC-1) and primary rat Leydig cells in a dose-dependent manner. However, PFDoA (1-100 microM) did not exhibit effects on cell viability and cellular ATP levels in mLTC-1 cells. PFDoA inhibited steroidogenic acute regulatory protein (StAR) promoter activity and StAR expression at the messenger RNA (mRNA) and protein levels but did not affect mRNA levels of peripheral-type benzodiazepine receptor, cholesterol side-chain cleavage enzyme, or 3beta-hydroxysteroid dehydrogenase in cAMP-stimulated mLTC-1 cells. PFDoA treatment also resulted in increased levels of mitochondrial ROS and H(2)O(2). After excessive ROS and H(2)O(2) were eliminated in PFDoA-treated mLTC-1 cells by MnTMPyP (a superoxide dismutase analog), progesterone production was partially restored and StAR mRNA and protein levels were partially recovered. These data show that PFDoA inhibits steroidogenesis in cAMP-stimulated Leydig cells by reducing the expression of StAR through a model of action involving oxidative stress.